Posts tagged with "(NASDAQ:MNKD)"

Can These Stocks Pull Up In Time? McDermott International (MDR), Penn Virginia Corporation (PVA) and MannKind Corporation (MNKD)

Posted by admin May 22, 2015 0 Comment 1924 views

New York, NY – GDP INSIDER  –  05/22/2015. This article discusses three companies: McDermott International (NYSE:MDR), Penn Virginia Corporation (NYSE:PVA) and MannKind Corporation (NASDAQ:MNKD) McDermott International (NYSE:MDR) increased by just over 3.24% in Thursday’s trading session to $4.78 from its previous closing price of $4.63.  The increase was not based on any news released by […]

Are These Stocks Facing Difficult Challenges? MannKind Corporation (MNKD), Halcon Resources Corp (HK) and Novovax Inc (NVAX)

Posted by admin March 24, 2015 0 Comment 1160 views

New York, NY – GDP INSIDER  –  03/24/2015. This articles discusses three companies: MannKind Corporation (NASDAQ:MNKD), Halcon Resources Corp (NYSE:HK) and Novovax Inc (NASDAQ:NVAX) MannKind Corporation (NASDAQ:MNKD) continued to decline yesterday with the stock losing 0.76% or $0.04 to close at $5.22 on light trading of 3.371 million shares, compared to its three month average […]

Are MannKind Corporation(NASDAQ:MNKD), Sanchez Energy Corp(NYSE:SN) and Warren Resources, Inc.(NASDAQ:WRES) Poised To Break Out?

Posted by admin January 13, 2015 0 Comment 1316 views

New York, NY – GDP INSIDER  –  01/13/2015. This article discusses three companies: MannKind Corporation(NASDAQ:MNKD), Sanchez Energy Corp(NYSE:SN) and Warren Resources, Inc.(NASDAQ:WRES) Alfred Mann, the founder of MannKind Corporation(NASDAQ:MNKD), has recently retired from his post as CEO. He will remain engaged to business matters as Executive Chairman. The $2.35 billion market cap company, which traded […]

MannKind Corporation (MNKD) And Sanofi SA (ADR) (SNY)’s Strategic Partnership

Posted by Lynn Eisler January 2, 2015 0 Comment 2179 views

MannKind Corporation (NASDAQ:MNKD) have pulled up its marketing gimmicks to ensure that it remains a strong contender in the rat race and lure investors in large numbers. Lately, it has gained an approval for rolling out the rampant sales after manufacturing of insulin Afrezza, from FDA. There have been tough times of cajoling as a […]

Do MannKind Corporation(NASDAQ:MNKD), Regado Biosciences Inc(NASDAQ:RGDO), and Sangamo Biosciences, Inc.(NASDAQ:SGMO) Have Strong Long-Term Outlooks?

Posted by admin October 5, 2014 0 Comment 2404 views

New York, NY – GDP INSIDER  –  10/06/2014. This article discusses three biopharamceutical companies: MannKind Corporation, Regado Biosciences, and Sangamo Biosciences. MannKind Corporation(NASDAQ:MNKD) is a California-based biopharmaceutical company that develops and commercializes therapeutic products for the treatment of diabetes and cancer. The company announced Oct. 3rd that it had received a $150 million upfront payment […]

MannKind Corporation (NASDAQ:MNKD) Announces Tentative Date For Afrezza Review

Posted by admin January 13, 2014 0 Comment 1561 views

MannKind Corporation (NASDAQ:MNKD), a development-stage biopharmaceutical company focussed on the development of therapies for diseases such as diabetes and cancer, saw its shares sanking as much as 17% last week soon after it announced a tentative date for the review of its inhaled diabetes medication, Afrezza, by the Endocrinologic and Metabolic Drugs Advisory Committee of […]

MannKind Corporation (NASDAQ:MNKD) Bets Big On Inhalable Diabetes Drug

Posted by Lynn Eisler January 7, 2014 0 Comment 1911 views

MannKind Corporation (NASDAQ:MNKD), the $1.66 billion market capped development stage biotech has another research and development cap in its crown as of January 2 this year. This was in the form of a new patent being granted to cover its new target compound “which directly inhibit IRE-1.alpha activity in vitro, prodrugs, and pharmaceutically acceptable salts […]

Will MannKind Corporation (NASDAQ:MNKD) Get Approval From FDA?

Posted by admin October 15, 2013 0 Comment 2040 views

MannKind Corporation (NASDAQ:MNKD) announced on October 14th, 2013 that it will be asking federal FDA to approve the marketing and even sales of their inhalable insulin powder and the name they have chosen is Afrezza. It is important to mention that FDA had initially declined the application put forth by the company two years back. […]

MannKind Corporation (NASDAQ:MNKD) Continues To Move Down

Posted by Ryan Mandell October 10, 2013 0 Comment 2241 views

 One sector which had a huge impact of Government shutdown was Biotechnology amidst growing concerns of US government defaulting. There is also a view among trading fraternity that biotech stocks are overvalued, hence recent sell off. MannKind Corporation (NASDAQ:MNKD) has seen a erosion of 21.65% in its market cap in last one month and it […]

Will AFREZZA Prove To Be MannKind Corporation (NASDAQ:MNKD)’s Wonder Drug?

Posted by Steve Raasch October 7, 2013 0 Comment 4188 views

MannKind Corporation (NASDAQ:MNKD) is all set to submit its AFREZZA NDA and its clinical progress is worth a look. The company had conducted 2, PhaseIII studies, both of which met their efficacy-endpoints. Another primary objective of Study 171 was to demonstrate the comparison between the MedTone and Gen-2 inhalers and this objective had been met. […]